Haemonetics (HAE) revenue breakdown
By segment, Hospital is the largest at 44% of fiscal 2026 revenue, growing 16% a year over 3 years.
By product, Plasma products and services is the largest at 48% of fiscal 2023 revenue; Hospital products and services grew fastest, 14% a year over 6 years.
Revenue by segment
Fiscal years, as Haemonetics reports them in its 10-K filings; fiscal 2026 total $1.3B.
| Segments | 2023 | 2024 | 2025 | 2026 | Share |
|---|---|---|---|---|---|
| Hospital | $382M | $456M | $564M | $588M | 44% |
| Plasma | $500M | $570M | $535M | $524M | 39% |
| Blood Center | $287M | $283M | $261M | $221M | 17% |
Revenue by product
Fiscal years, as Haemonetics reports them in its 10-K filings; fiscal 2023 total $1.2B.
| Products | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | Share |
|---|---|---|---|---|---|---|---|---|
| Plasma products and services | $411M | $436M | $502M | $537M | $414M | $428M | $564M | 48% |
| Hospital products and services | $171M | $183M | $197M | $198M | $217M | $329M | $378M | 32% |
| Blood Center products and services | $304M | $285M | $269M | $253M | $240M | $236M | $227M | 19% |
Revenue by region
Fiscal years, as Haemonetics reports them in its 10-K filings; fiscal 2026 total $1.3B.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $523M | $549M | $607M | $646M | $523M | $639M | $843M | $970M | $1.0B | $982M | 74% |
| Europe | $166M | $164M | $165M | $153M | $159M | $164M | $157M | $160M | $176M | $185M | 14% |
| Rest of Asia | $110M | $115M | $119M | $109M | $106M | $111M | $104M | $108M | $92M | $87M | 7% |
| Japan | $79M | $67M | $70M | $72M | $78M | $76M | $61M | $58M | $62M | $68M | 5% |
| Other | $8M | $9M | $8M | $7M | $5M | $4M | $4M | $13M | $20M | $11M | 1% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for HAE.
Open HAE in InvestinglyQuestions
Where does Haemonetics make its money?
In fiscal 2026, by segment: Hospital $588M, Plasma $524M, Blood Center $221M.
From Haemonetics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.